Clinical Trials Logo

Clinical Trial Summary

Autologous glue therapy with platelet-rich plasma (PRP) was reported to improve outcomes in plastic surgery. However, only pilot studies and retrospective uncontrolled trials have reported the potential benefits of autologous glue treatment up to now. Therefore, a larger, blinded, randomized and placebo-controlled clinical trial would be useful to determine whether platelet-rich plasma is safe and effective in abdominoplasty procedures.

Currently, there are pharmacological options such as artificial fibrin glues composed of homologous fibrinogen and animal-derived thrombin. However, these therapeutics present a risk of transmissible diseases and may induce allergic reactions. Therefore, autologous glues, which are fully made of blood components from the patient itself (autologous fibrinogen contained in PRP and autologous thrombin) represents a safe alternative to artificial biological glues.

Regen Lab SA developed RegenKit®-Surgery to prepare autologous PRP, on one hand, and an autologous activated thrombin serum, on the other hand, in a safe and rapid manner. RegenKit®-Surgery is a CE-marked class IIb medical device.

This study, conducted on 56 patients, will evaluate the effects of autologous glue prepared with RegenKit®-Surgery when used in reconstructive abdominoplasty.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT02930447
Study type Interventional
Source Regen Lab SA
Contact Valérie de Fourmestraux, PhD
Phone +41(0)218640110
Status Not yet recruiting
Phase N/A
Start date January 2018
Completion date December 2019

See also
  Status Clinical Trial Phase
Completed NCT03143959 - Functional Improvement With Abdominoplasty N/A
Completed NCT02949778 - Quadratus Lumborum Block for Abdominoplasty Phase 4
Active, not recruiting NCT01026662 - In-vivo Analysis of a Fractional CO2 Laser System (eMatrixCO2) Intended for Treatment of Soft Tissue Phase 2/Phase 3
Recruiting NCT03770195 - Registry Study for the Use of HEMOBLAST™ Bellows in Abdominoplasty
Terminated NCT03429556 - Study to Evaluate EB-001 in Reducing Musculoskeletal Pain in Abdominoplasty Phase 2
Completed NCT02302222 - The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing N/A
Completed NCT01389635 - Abdominoplasty Under Epidural Anesthesia N/A
Recruiting NCT03190876 - Seroma Prevention After Body Contouring Procedures N/A
Completed NCT01604694 - Ultrasound-guided Transversus Abdominis Plane Block for Analgesia After Abdominoplasty Phase 4
Withdrawn NCT02140385 - Role of Preservation of Scarpa's Fascia in Abdominoplasty N/A
Recruiting NCT03467724 - Treatment of Surgical Scars Following Breast Augmentation, Abdominoplasty or Face Lift N/A
Completed NCT01331798 - Evaluation of Cohera TissuGlu in the Management of Wound Drainage Following Abdominoplasty Phase 1/Phase 2
Completed NCT03246971 - Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain Phase 2
Unknown status NCT01175889 - Megadyne Ace Incision/Dissection Study Phase 4
Completed NCT01526954 - Cohera TissuGlu® Surgical Adhesive in the Management of Wound Drainage Phase 2/Phase 3